Artisan Partners Limited Partnership Purchases New Holdings in Heartflow, Inc. $HTFL

Artisan Partners Limited Partnership purchased a new position in shares of Heartflow, Inc. (NASDAQ:HTFL) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 499,622 shares of the company’s stock, valued at approximately $16,817,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. TFC Financial Management Inc. bought a new position in shares of Heartflow in the third quarter valued at $40,000. Emerald Mutual Fund Advisers Trust acquired a new stake in Heartflow in the third quarter valued at $4,418,000. TrueMark Investments LLC acquired a new position in shares of Heartflow during the 3rd quarter worth about $918,000. Baillie Gifford & Co. bought a new stake in shares of Heartflow in the 3rd quarter valued at about $101,182,000. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Heartflow in the 3rd quarter valued at about $234,000.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Canaccord Genuity Group boosted their price target on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Heartflow in a research note on Monday, December 29th. Stifel Nicolaus increased their price target on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. JPMorgan Chase & Co. raised their price target on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Finally, Wells Fargo & Company began coverage on shares of Heartflow in a report on Wednesday, January 28th. They issued an “overweight” rating and a $38.00 price objective on the stock. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $38.50.

Heartflow Trading Down 3.9%

Shares of NASDAQ HTFL opened at $23.16 on Friday. The firm has a market cap of $1.97 billion and a P/E ratio of -12.80. The business’s 50 day moving average is $29.09 and its 200-day moving average is $31.22. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $41.22.

Insider Activity at Heartflow

In other Heartflow news, insider Campbell Rogers sold 65,153 shares of the stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $24.49, for a total transaction of $1,595,596.97. Following the transaction, the insider owned 76,034 shares in the company, valued at $1,862,072.66. This represents a 46.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeffrey C. Lightcap bought 40,000 shares of the stock in a transaction dated Tuesday, December 16th. The shares were acquired at an average cost of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the acquisition, the director directly owned 40,000 shares of the company’s stock, valued at approximately $1,053,600. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have sold 2,095,715 shares of company stock valued at $58,533,709.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.